Joke Bilcke

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. doi request reprint Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?
    Joke Bilcke
    Center for Health Economic Research and Modeling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
    Vaccine 30:2795-800. 2012
  2. ncbi request reprint The health and economic burden of chickenpox and herpes zoster in Belgium
    J Bilcke
    Center for Health Economic Research and Modeling Infectious Diseases, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
    Epidemiol Infect 140:2096-109. 2012
  3. doi request reprint Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium
    Joke Bilcke
    Center for Health Economics Research and Modeling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    Vaccine 30:675-84. 2012
  4. ncbi request reprint The health and economic burden of rotavirus disease in Belgium
    Joke Bilcke
    Unit for Health Economics and Modelling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    Eur J Pediatr 167:1409-19. 2008
  5. pmc Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis
    Joke Bilcke
    Centre for Health Economics Research and Modeling of Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Wilrijk, Antwerp, Belgium
    PLoS ONE 4:e6060. 2009
  6. doi request reprint Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources
    Joke Bilcke
    Centre for Health Economics Research and Modelling of Infectious Diseases CHERMID, Centre for the Evaluation of Vaccination CEV, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    Pharmacoeconomics 27:281-97. 2009
  7. doi request reprint Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium
    Joke Bilcke
    Centre for Health Economics and Modelling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Belgium
    Med Decis Making 29:33-50. 2009
  8. ncbi request reprint Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all
    Joke Bilcke
    Centre for Health Economics Research and Modelling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO WHO collaborating Centre, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
    PLoS ONE 9:e102634. 2014
  9. pmc Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians
    Benson Ogunjimi
    Centre for Health Economics Research and Modeling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    Clin Vaccine Immunol 21:417-26. 2014
  10. doi request reprint Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide
    Joke Bilcke
    Center for Health Economic Research and Modeling for Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, Antwerp University, Antwerp, Belgium
    Med Decis Making 31:675-92. 2011

Detail Information

Publications10

  1. doi request reprint Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?
    Joke Bilcke
    Center for Health Economic Research and Modeling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
    Vaccine 30:2795-800. 2012
    ..Only one study estimated vaccine efficacy by age at vaccination and time since vaccination combined. Recently, data became available from the same trial for a follow-up period of 7 years...
  2. ncbi request reprint The health and economic burden of chickenpox and herpes zoster in Belgium
    J Bilcke
    Center for Health Economic Research and Modeling Infectious Diseases, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
    Epidemiol Infect 140:2096-109. 2012
    ..The quality-adjusted life years lost for ambulatory CP patients consulting a physician is more than double that of those not consulting a physician (0·010 vs. 0·004). In conclusion, both diseases cause a substantial burden in Belgium...
  3. doi request reprint Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium
    Joke Bilcke
    Center for Health Economics Research and Modeling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    Vaccine 30:675-84. 2012
    ..To assess the cost-effectiveness of vaccinating all or subgroups of adults aged 60 to 85 years against herpes zoster...
  4. ncbi request reprint The health and economic burden of rotavirus disease in Belgium
    Joke Bilcke
    Unit for Health Economics and Modelling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    Eur J Pediatr 167:1409-19. 2008
    ..This burden is estimated to represent direct costs of 7.7 million Euro and indirect costs of 12.8 million Euro. Rotavirus disease causes a substantial health and economic burden in Belgium...
  5. pmc Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis
    Joke Bilcke
    Centre for Health Economics Research and Modeling of Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Wilrijk, Antwerp, Belgium
    PLoS ONE 4:e6060. 2009
    ....
  6. doi request reprint Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources
    Joke Bilcke
    Centre for Health Economics Research and Modelling of Infectious Diseases CHERMID, Centre for the Evaluation of Vaccination CEV, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    Pharmacoeconomics 27:281-97. 2009
    ..Furthermore, future analyses may have to consider ways of accounting for herd immunity (e.g. by using a dynamic model)...
  7. doi request reprint Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium
    Joke Bilcke
    Centre for Health Economics and Modelling Infectious Diseases, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Belgium
    Med Decis Making 29:33-50. 2009
    ..To estimate the cost-effectiveness of universal childhood rotavirus vaccination in Belgium, taking into account the impact of caregiver burden and the burden of sick children for whom no medical care is sought ("no medical care'' )...
  8. ncbi request reprint Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all
    Joke Bilcke
    Centre for Health Economics Research and Modelling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO WHO collaborating Centre, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
    PLoS ONE 9:e102634. 2014
    ..In particular to inform the evaluation of more widespread seasonal influenza vaccination, including in children, which is currently considered by many countries. ..
  9. pmc Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians
    Benson Ogunjimi
    Centre for Health Economics Research and Modeling Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    Clin Vaccine Immunol 21:417-26. 2014
    ..Repetitive exposures to VZV have been shown to induce a stable increased level of VZV-specific cellular but not humoral immunity. Based on our observations, VZV IE63 can be considered a candidate for a zoster vaccine. ..
  10. doi request reprint Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide
    Joke Bilcke
    Center for Health Economic Research and Modeling for Infectious Diseases CHERMID, Vaccine and Infectious Disease Institute VAXINFECTIO, Antwerp University, Antwerp, Belgium
    Med Decis Making 31:675-92. 2011
    ....